← Back to Vaccine Database

AZD2816

Viral vector (Non-replicating) vaccine · VDDBV0109

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04973449 Phase 3COVID-19